Skip to main content
Log in

Level of hypertension control: comparison of a rural and urban family practice centre in South Croatia

Einstellung der Hypertonie: Vergleich der Ergebnisse in einem Praxiszentrum am Land mit denen einer städtischen Familienpraxis

  • original article
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Summary

Aim

Arterial hypertension is a serious public health problem because of its frequency and poor management. We compared hypertension control between rural and urban environment over 5 years. Initial hypothesis: arterial pressure control is better in urban (Split) than in rural (Trilj) environment.

Methods

Historic prospective study was conducted in two family medicine outpatient clinics. Data for the years 2005, 2006, and 2010 were analyzed. One hundred and seventeen subjects diagnosed with arterial hypertension in 2005 were examined: 66 in a rural and 51 in urban outpatient clinic. Their average age was 60.92 ± 10.03 (range 30–82 years). Blood pressure records at the onset of the study, the first, and fifth year of treatment, risk factors, and therapy were analyzed. T-test and χ2-test were used in statistical data analysis.

Results

In the urban clinic, more subjects were smokers, had positive family history, were overweight, and had registered hyperlipidemia. Initial mean arterial pressure readings were similar in both the clinics. Decrease was recorded in the following 5 years. During this study the use of ACE inhibitors (ACEI) (Split by 45 %, Trilj by 133 %) and calcium channel blockers (CCB) (Split by 76.9 %, Trilj by 525 %) was increased. The number of patients receiving monotherapy was reduced.

Conclusions

Better arterial pressure control was recorded in the urban clinic, where, after 5 years, despite increased frequency of additional risk factors, the number of normotensive patients was higher than that in the rural one. Hypertension control in both settings was still poor. Hypertensive patients should participate actively in the treatment.

Zusammenfassung

Ziel der Studie

Auf Grund der Häufigkeit und des oft schlechten Managements ist die Hypertonie ein ernstes Problem des öffentlichen Gesundheitswesens. Wir verglichen die Einstellung der Hypertonie über 5 Jahre in einer ländlichen Umgebung mit der einer städtischen. Die anfängliche Hypothese war, dass die Hypertonie- Kontrolle in einer Stadt (Split) besser als am Land (Trilj) sein müsste.

Methodik

In einer historisch-prospektiven Studie wurden die Daten von 2005, 2006 und 2010 zweier Familienpraxen ausgewertet. 117 Patienten (66 aus der ländlichen, 51 aus der städtischen Praxis), bei denen 2005 eine Hypertonie festgestellt worden war, wurden untersucht: das mittlere Alter war 60,92 ± 10,03 (30–82) Jahre. Die RR-Werte vom Beginn der Studie, nach einem Jahr und nach 5 Jahren wurden erhoben. T-Test und χ2-Test wurden zu statistischen Auswertung verwendet.

Ergebnisse

In der städtischen Praxis war die Anzahl der Raucher, der Patienten mit einer positiven Familienanamnese, mit Übergewicht und mit dokumentierter Hyperlipidämie höher. Die initialen RR-Werte waren in beiden Praxen ähnlich. In den folgenden 5 Jahren wurde ein Abfall festgestellt. Während der Studie stieg der Einsatz von ACE-Hemmern (in Split um 45 %, in Trilj um 133 %) und Calciumkanalblocker (in Split um 76,9 %, in Trilj um 525 %). Die Anzahl der Patienten mit Monotherapie wurde reduziert.

Schlussfolgerungen

Die Blutdruckeinstellung war in der städtischen Praxis besser. Nach 5 Jahren war die Zahl der normotensiven Patienten trotz der höheren Häufigkeit von zusätzlichen Risikofaktoren höher als in der Land-Praxis. Die Kontrolle des Hochdrucks war in beiden Praxen noch immer mangelhaft. Patienten mit Hypertonie sollten aktiv an der Behandlung teilnehmen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA. 1996;275:1571–6.

    Article  Google Scholar 

  2. World Health Organization/International Society of Hypertension. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983–92.

    Article  Google Scholar 

  3. Wang KL, Cheng HM, Chuang SY, et al. Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality? J Hypertens. 2009;27:461–7.

    Article  PubMed  CAS  Google Scholar 

  4. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 Guidelines for the management of arterial hypertension. J Hypertens. 2007;25:1105–87.

    Article  Google Scholar 

  5. Simoons ML, Van Der Putten N, Wood D, Boersma E, Bassand JP. The cardiology information system: the need for data standards for integration of systems for patient care, registries and guidelines for clinical practice. Eur Heart J. 2002;23:1148–52.

    Article  PubMed  CAS  Google Scholar 

  6. Zanchetti A, Mancia G, Black HR, et al. Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension. J. Hypertens. 2009;27:673–9.

    Article  PubMed  CAS  Google Scholar 

  7. Jelaković B, Dika Ž, Kos J, et al. Liječenje i kontrola arterijske hipertenzije u Hrvatskoj (Arterial hypertension treatment and control in Croatia. Summary in English). BEL-AH study. Liječ Vjesn. 2006;128:329–33.

    Google Scholar 

  8. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011–53.

    Article  Google Scholar 

  9. Pavličević I. Značaj interakcije antihipertenziva i antireumatika u ordinaciji liječnika obiteljske medicine. (Signifiance of antypertensive and antirheumatic drugs in family practice centres. Summary in English). (Doctoral dissertation) Split: Medicinski fakultet Sveučilišta u Splitu; 2009.

    Google Scholar 

  10. Verdecchia P, Staessen JA, Angeli F, et al. Usual versus tight control of systolic blood pressure in nondiabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet. 2009;374:525–33.

    Article  PubMed  Google Scholar 

  11. Zanchetti A, Grassi G, Mancia G. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal. J Hypertens. 2009;27:923–34.

    Google Scholar 

  12. Vrhovac B. Interna medicina (Internal medicine). 3rd edition. Zagreb: Naklada ljevak; 2003. pp. 566–84.

  13. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–98.

    Article  PubMed  CAS  Google Scholar 

  14. Waeber B, de la Sierra A, Ruilope LM. Target organ damage: how to detect it and how to treat it? J Hypertens. 2009;27 (Suppl 3):13–8.

    Article  Google Scholar 

  15. Paulsena MS, Sondergaarda J, Reutherb L, et al. Treatment of 5413 hypertensive patients: a cross-sectional study. Family Practice. 2011;28(6):599–607.

    Article  Google Scholar 

  16. Stipešević Rakamarić I. Nejednakosti mortaliteta u urbanim i ruralnim sredinama Hrvatske (The uneven mortality rate in urban and rural areas of Croatia. Summary in English) (Magister thesis). Zagreb: Medicinski fakultet Sveučilišta u Zagrebu; 2011.

    Google Scholar 

  17. New Zealand Guidelines Group. New Zealand Primary Care Handbook 2012. 3rd edition Wellington: New Zealand Guidelines Group; 2012.

    Google Scholar 

  18. Krause T, Lovibond K, Caulfield M, McCormack T, Williams B. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:d6255.

    Article  Google Scholar 

  19. Yusuf S, Islam S, Chow CK, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle- income, and low-income countries (the PURE Study): a prospective epidemiological survey. The Lancet. 2011;378(9798):1231–43.

    Article  Google Scholar 

  20. Morgan A. A national call to action: CDC’s 2001 urban and rural health chartbook. J Rural Health. 2002;18:382–3

    Article  PubMed  Google Scholar 

  21. Chang L, McAlister AL, Taylor WC, Chan W. Behavioral change for blood pressure control among urban and rural adults in Taiwan. Health Promot Int. 2003; 18(3):219–28.

    Article  PubMed  Google Scholar 

  22. Phillips CD, McLeroy KR. Health in rural America: remembering the importance of place. Am J Public Health. 2004;94(10):1661–3.

    Article  PubMed  Google Scholar 

  23. Murimi MW, Harpel T. Practicing preventive health: the underlying culture among low-income rural populations. J Rural Health. 2010;26(3):273–82.

    Article  PubMed  Google Scholar 

  24. Jerčić M, Čizmić Z, Vujević M, Puljiz T. Practical training of family medicine in the Dalmatian Hinterland: first hand experience of four physicians. Acta Medica Academica. 2012;41(1):93–9.

    PubMed  Google Scholar 

  25. Pavličević I. The new curriculum for family medicine at the University of Split School of medicine. Acta Medica Academica. 2012;41(1):26–37.

    PubMed  Google Scholar 

  26. Yapp CK, Taylor LS, Ow CY, Jamrozik K, Puddey IB. Hypertension management: a comparison of urban versus rural general practitioners in Western Australia. Clin Exp Pharmacol Physiol. 1995;22(6–7):447–9.

    Article  PubMed  CAS  Google Scholar 

  27. Burnier M, Santschi V, Favrat B, Brunner HR. Monitoring compliance in resistant hypertension: an important step in patient management. J Hypertens. 2003;21(Suppl 2):37–42.

    Article  Google Scholar 

  28. Philips LS, Branch WT, Cook BC, et al. Clinical Inertia. Ann Intern Med. 2001;135:825–34.

    Article  Google Scholar 

  29. Conlin PR, Gerth WC, Fox J, Roehm JB, Boccuzzi SJ. Four-year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other antihypertensive drug classes. Clin Ther. 2001;23:1999–2010.

    Article  PubMed  CAS  Google Scholar 

  30. Ong L K, Cheung BM, May BY, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension. 2007;49:69–75.

    Article  PubMed  CAS  Google Scholar 

  31. Jelaković B, Željković-Vrkić T, Pećin I, et al. Epidemiology of hypertension in Croatia. EHUH study. J Hypertens. 2006;24(4):242.

    Google Scholar 

  32. Wolf-Maier K, Cooper RS, Kramer H. Hypertension treatment and control in 6 European countries, Canada, and the United States. Hypertension. 2004;43:10–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that there is no actual or potential conflict of interest in relation to this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ivančica Pavličević MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Čikara, A., Pavličević, I. & Perić, I. Level of hypertension control: comparison of a rural and urban family practice centre in South Croatia. Wien Klin Wochenschr 125, 173–179 (2013). https://doi.org/10.1007/s00508-013-0339-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-013-0339-x

Keywords

Schlüsselwörter

Navigation